We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
Cap. Flow
-$59.5M
Cap. Flow %
-0.14%
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128

Sector Composition

Rank Sector Weight
1 Financials 16.4%
2 Technology 15.29%
3 Healthcare 13.69%
4 Industrials 10.84%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXA
2776
DELISTED
EXA Corporation
EXA
$191K ﹤0.01%
13,871
+605
+5% +$8.14K
ABEO icon
2777
Abeona Therapeutics
ABEO
$354M
$190K ﹤0.01%
+1,185
New +$162K
LAYN
2778
DELISTED
Layne Christensen Co
LAYN
$190K ﹤0.01%
21,629
+1,755
+9% +$14.3K
NODK icon
2779
NI Holdings
NODK
$315M
$188K ﹤0.01%
+10,538
New +$176K
MBTF
2780
DELISTED
MBT Financial Corporation
MBTF
$188K ﹤0.01%
19,340
+260
+1% +$2.79K
ORM
2781
DELISTED
Owens Realty Mortgage, Inc.
ORM
$188K ﹤0.01%
11,083
+420
+4% +$7.22K
FCFP
2782
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
$187K ﹤0.01%
14,472
+715
+5% +$9.2K
HIL
2783
DELISTED
Hill International, Inc. Common Stock
HIL
$186K ﹤0.01%
35,778
-209
-0.6% -$948
FBIO icon
2784
Fortress Biotech
FBIO
$114M
$185K ﹤0.01%
2,590
+72
+3% +$4.25K
TIPT icon
2785
Tiptree Inc
TIPT
$693M
$185K ﹤0.01%
26,216
+845
+3% +$5.72K
PVLA
2786
Palvella Therapeutics
PVLA
$2.08B
$184K ﹤0.01%
+454
New +$133K
ESXB
2787
DELISTED
Community Bankers Trust Corporation
ESXB
$184K ﹤0.01%
+22,275
New +$179K
LUMO
2788
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$183K ﹤0.01%
2,772
-36
-1% -$4.46K
ESCA icon
2789
Escalade
ESCA
$273M
$182K ﹤0.01%
13,875
+647
+5% +$8.19K
WAAS
2790
DELISTED
AquaVenture Holdings Limited
WAAS
$182K ﹤0.01%
+11,962
New +$204K
RYZ
2791
Ryerson Holding Corp
RYZ
$1.48B
$180K ﹤0.01%
18,139
+3,740
+26% +$39.7K
MACK
2792
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$180K ﹤0.01%
18,441
+573
+3% +$11.7K
IMH
2793
DELISTED
Impac Mortgage Holdings Inc.
IMH
$180K ﹤0.01%
11,918
+980
+9% +$14.7K
BOCH
2794
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$178K ﹤0.01%
+16,092
New +$178K
AMBR
2795
DELISTED
Amber Road Inc
AMBR
$177K ﹤0.01%
20,675
+2,305
+13% +$18K
DGICA icon
2796
Donegal Group Class A
DGICA
$717M
$176K ﹤0.01%
11,052
+40
+0.4% +$652
CLAR icon
2797
Clarus
CLAR
$126M
$175K ﹤0.01%
+26,500
New +$156K
FBM
2798
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$175K ﹤0.01%
+13,643
New +$204K
AFH
2799
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$175K ﹤0.01%
11,737
+290
+3% +$4.09K
AMRC icon
2800
Ameresco
AMRC
$1B
$174K ﹤0.01%
22,614
-3,150
-12% -$21.2K

Similar funds

RhumbLine Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
  • RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
  • RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
  • RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
  • RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
  • RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.